Herpes-simplex virus (HSV) in pulmonary tuberculosis (TB) with delayed response to treatment in patients from radio-nuclide contaminated areas (RNCA) Source: Eur Respir J 2002; 20: Suppl. 38, 558s Year: 2002
The use of phon resonant therapy (PRT) in treatment of patients with pulmonary tuberculosis, combined with infections, caused by chlamydia (C) and mycoplasma (M) Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004
Observation of pregnant women (PW) after severe pneumonia (P) with influenza A/H1N1 virus infection in 2009-2010: Long-term results Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011
Safety of the endobronchial valve use in the complex treatment of patients with destructive MDR/XDR TB associated with HIV infection. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Diffusion ability of the lungs in the assessment of respiratory function in patients who have undergone the new coronavirus infection (COVID-19) Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Clinical feature of 4 cases of severe pneumonia in pregnant women with influenza A(H1N1) virus infection Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010
The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen Source: Eur Respir J 2003; 21: 785-788 Year: 2003
The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005
A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Immunity status of community acquired pneumonia (CAP) young patients according concomitant cytomegalovirus persistence (CMVP) Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Comparison the frequency of human T-lymphocyte type 1 (HTLV 1) infection in tuberculosis patients with control group without tuberculosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011
State of immunity at children with a bronchial asthma (BA) and acute respiratory virus infection (ARVI) Source: Eur Respir J 2007; 30: Suppl. 51, 644s Year: 2007
Respiratory viral point of care testing (POCT) allows improved infection control and bed management during an influenza outbreak Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018
Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
Efficacy of inductor of endogenous interferon's, cyclopheroni, in treatment of children with frequent acute respiratory infection (FARI) Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001
Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020
IFN-γ response on T-cell based assays for the diagnosis of tuberculosis infection in rheumatic patients undergoing anti-TNF-α treatment Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009
Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection? Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021
Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients Source: Eur Respir J 2002; 20: 28S-39S Year: 2002
High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012